Second dose gets a short shrift?

Many have become complacent ignoring COVID-19 third wave risk, say experts

July 22, 2021 11:59 pm | Updated 11:59 pm IST - VIZIANAGARAM

A woman being vaccinated at a session site in Vizianagaram on Thursday.

A woman being vaccinated at a session site in Vizianagaram on Thursday.

A majority of people are said to be ignoring vaccination in spite of availability of sufficient doses at the Primary Health Centres and other designated places in the district.

Till a couple of months ago, people used to throng the PHCs for getting vaccinated against coronavirus. Now officials and medical staff are requesting people to have the first dose of the vaccine immediately since a third wave of the pandemic is likely in near future. However, there is little response to their pleas, thanks to the significant drop in new infections in the district. From around 500 a day in April and May, daily new infections are under 100 in the district now. On Thursday the number of new COVID-19 cases was only 29.

Collector M. Hari Jawaharlal has directed the District Medical and Health Department officials to oversee the vaccination programme on a daily basis. As many as 7,23,783 persons were administered the first dose of the vaccine and 1,73,939 the second dose. The recommended gap between two doses is four weeks for Covaxin and up to 12 weeks for Covishield. Many, for whom the second dose is due, are said to be not keen on it.

Publicity

Programme Officer for vaccination E. Gopala Krishna told The Hindu that the district administration was giving wide publicity on the availability of vaccines at all 80 designated centres. “The second dose of the vaccine is important since it would strengthen the immunity system to fight coronavirus efficiently,” he said.

“Many people think that the first dose is sufficient to get the required immunity. But the second dose is needed for human body to fight new variants of coronavirus as per the recommendations of the World Health Organisation and the Indian Council of Medical Research,” said Dr. Kurella Srinivas.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.